John B Bode
Director at SPAR Group, Inc. (SGRP) since October 2023
John B Bode has filed 14 insider reports with the SEC since May 2023, as director at SPAR Group, Inc. (SGRP), director at Zevra Therapeutics, Inc. (ZVRA) and director at Newton Golf Company, Inc. (NWTG). John B Bode made no open-market purchases or sales in the last 12 months. The latest filing, on October 2, 2026, reports grant or award at SPAR Group, Inc. (SGRP).
- Filings
- 14
- Companies
- 3
- Bought on market
- $286K
- Sold on market
- None
Companies where John B Bode is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince October 2023 | 110,000 | $0.2875 | Oct 2, 2026 | ||||
| Directorsince April 2023 | 123,400 | $286K | $6.35 | $9.40+48% | Mar 26, 2026 | ||
| Directorsince January 2026 | 18,549 | $0.7072 | Feb 4, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 29, 2026SGRPDirector Bode John B was granted 110,000 sharesForm 4Grant or award
- Mar 24, 2026ZVRASEC Form 4 filed by Bode John BForm 4Exercise or conversion of a derivative
- Jan 30, 2026NWTGDirector Bode John B was granted 18,549 sharesForm 4Grant or award
- Jan 30, 2026NWTGJohn B Bode became an insiderForm 3New insider
- Aug 19, 2025+$45.8KZVRADirector Bode John B bought $45,825 worth of shares (5,000 units at $9.16), increasing direct ownership by 12% to 45,000 unitsForm 4Open-market purchase
- May 29, 2025ZVRASEC Form 4 filed by Director Bode John BForm 4Grant or award
- Mar 19, 2025+$79.6KZVRADirector Bode John B bought $79,624 worth of shares (10,000 units at $7.96), increasing direct ownership by 33% to 40,000 unitsForm 4Open-market purchase
- Jul 12, 2024+$58.7KZVRADirector Bode John B bought $58,661 worth of shares (10,000 units at $5.87), increasing direct ownership by 50% to 30,000 unitsForm 4Open-market purchase
- May 13, 2024ZVRASEC Form 4 filed by Bode John BForm 4Grant or award
- Oct 1, 2023SGRPJohn B Bode became an insiderForm 3New insider
- Sep 5, 2023+$51.3KZVRASEC Form 4: Bode John B bought $51,333 worth of shares (10,000 units at $5.13), increasing direct ownership by 100% to 20,000 unitsForm 4Open-market purchase
- May 18, 2023+$50.4KZVRASEC Form 4 filed by Bode John BForm 4Open-market purchase
- May 3, 2023ZVRASEC Form 4 filed by Bode John BForm 4Grant or award
- Apr 25, 2023ZVRAJohn B Bode became an insiderForm 3New insider
Compare John B Bode with
- John B Bode vs Brett Widney Hoge1 shared
- John B Bode vs Robert G/ Brown1 shared
- John B Bode vs Timothy Patrick Cook1 shared
- John B Bode vs Linda M Houston1 shared
- John B Bode vs William Linnane1 shared
- John B Bode vs Rahsaan Thompson1 shared
Other insiders at the same companies
- ReposiTrak, Inc.SGRP
- Brett Widney HogeNWTG
- Robert G/ BrownSGRP
- Timothy Patrick CookSGRP
- Linda M HoustonSGRP
- William LinnaneSGRP
- Rahsaan ThompsonZVRA
- Corey Michael WattonZVRA
- William H BartelsSGRP
- Jane CasantaNWTG
- Akinobu YorihiroNWTG
- Jeff ClayborneNWTG
- Tamara A FavoritoZVRA
- Alicia SecorZVRA
- Douglas W CalderZVRA
- Thomas AndersonZVRA
Questions about John B Bode
- What is John B Bode's role at SPAR Group, Inc.?
- John B Bode reports to the SEC as director at SPAR Group, Inc. (SGRP), according to the latest filing on October 2, 2026. John B Bode has also filed as director at Zevra Therapeutics, Inc. (ZVRA) and director at Newton Golf Company, Inc. (NWTG).
- How many shares does John B Bode own?
- After the latest filing that states it, John B Bode directly owned 110,000 shares of SPAR Group, Inc. (SGRP), 123,400 shares of Zevra Therapeutics, Inc. (ZVRA) and 18,549 shares of Newton Golf Company, Inc. (NWTG). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has John B Bode bought or sold stock recently?
- The most recent open-market purchase was on August 19, 2025: bought 5,000 shares of Zevra Therapeutics, Inc. (ZVRA) for $45.8K at an average of $9.16.
- How do I get alerts when John B Bode files?
- Follow John B Bode on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. John B Bode filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by John B Bode (SEC CIK 0001612084). Totals count each trade once, skipping amendments whose original is on file, from May 9, 2023 on. View on SEC EDGAR